Multidisciplinary management of diabetic kidney disease: a systematic review protocol
Nancy Helou,Andrew Dwyer,Michel Burnier,Maya Shaha,Anne Zanchi
DOI: https://doi.org/10.11124/jbisrir-2014-1543
2014-07-01
JBI Database of Systematic Reviews and Implementation Reports
Abstract:Review question/objective The goal of this systematic review is to identify the best available evidence regarding multidisciplinary management of diabetes related kidney disease. More specifically, this analysis aims to answer the question: is the multidisciplinary management of diabetic kidney disease effective in improving health‐related patient outcomes? Background The growing rate of diabetes poses significant practice and economic related challenges to healthcare systems around the world.1 Diabetes carries significant risks for negative health sequelae and as such, Diabetic Kidney Disease (DKD) is becoming a global health concern.2 Despite pharmacologic advances and disease management strategies, DKD remains associated with high morbidity and mortality.3 Non‐adherence to the treatment regimen is considered to be the major cause of the poor glycemic control and resultant complications often seen in patients with diabetes.4 Systematic reviews of the literature focusing on other chronic diseases have suggested that multidisciplinary management of chronic conditions can improve patients' adherence to treatment and improve health related outcomes.5, 6 However, the effectiveness of multidisciplinary management in improving or optimizing outcomes of patients with DKD has yet to be established in a systematic manner. DKD is a progressive disease associated with multiple comorbidities, major complications and increased healthcare costs. It affects approximately 30% to 40% of diabetic patients.7,8 The prevalence of DKD is projected to continue to rise9, mainly in proportion to the rise in the prevalence of diabetes.10 Patients with DKD have the highest risk of morbidity among diabetic patients.11 DKD carries a poor prognosis, with increased all‐cause mortality and cardiovascular mortality; a risk of progressive renal function decline and acute renal failure, leading to end‐stage renal disease.12,13,14 DKD is the most common cause of end stage renal disease in both the United States and Europe.15 In fact, patients with DKD account for half of dialysis cases.3 Disease progression is associated with frequent hospitalizations and dialysis, events that increase healthcare costs considerably.16 Moreover, decreased kidney function is also associated with compromised health related quality of life. As the rate of kidney function declines, disease burden increases concordant with diminished quality of life measures.17 These findings have been further supported by a cross sectional study demonstrating that patients with stage four and five kidney disease have a compromised quality of life, with similar levels to patients on dialysis.18 Accordingly, targets for interventions aimed at improving the management of DKD have included: improving patient outcomes such as functional status, quality of life and adherence to treatment19, and preventing the progression of the disease and the occurrence of cardiovascular complications.8 The treatment of DKD typically involves controlling blood pressure, glycaemia and lipids. Additional management steps include screening for retinopathy or neuropathy, along with patient education, training in self‐management and lifestyle modification coaching.20 This is important as patients with multiple chronic diseases, such as DKD, often live at home and are expected to manage a wide range of daily selfcare activities including monitoring of blood glucose levels, adjusting nutrition, engaging in physical activity, adhering to medication regimens, recognizing symptoms of deterioration in status and responding accordingly, and to reduce their risk of complications and adjust psychologically to their treatment and lifestyle changes.21 Patients are often unable to suitably interpret the multitude of instructions received from various health care professionals and to process the complexity of the treatment regimens.22 These challenges can pose barriers for adherence and non‐adherence is thought to be the major cause for the poor control of diabetes and a significant contributor to the occurrence of complications.4 One approach to address these problems in patients with DKD involves multidisciplinary management of different comorbidities to slow the progression of the disease and prevent complications. Black and colleagues (2010) have recommended the shifting of multidisciplinary management of end stage kidney disease to the management of patients with evidence of early stage chronic kidney disease.23 Stamm, Burnier and Zanchi (2011) have noted the need for comprehensive multidisciplinary care that would optimize the care of patients with DKD.24 They advocate for a multidisciplinary nurse led team composed of an endocrinologist, nephrologist, clinical nurse specialist, dietitian, pharmacist and podiatrist. In relation to other chronic diseases such as heart failure and diabetes, systematic reviews of the literature and meta‐analyses support the effectiveness of multidisciplinary management programs such as nurse led clinical management programs, multidisciplinary home visit management programs and multidisciplinary home telemanagement programs. These approaches have demonstrated enhanced patient outcomes in terms of reducing costs, re‐hospitalization rates and mortality, increasing health literacy and adherence to treatment, and ameliorating patients' functional status, self‐care abilities and quality of life.25‐30 While, these systematic reviews support the benefit of multidisciplinary management of chronic disease, only a paucity of studies exist in nephrology regarding the care of DKD patients. DKD is a chronic disease similar to diabetes. However, patients with DKD have specific needs that differ from patients with diabetes. A study using the Kidney Disease Quality of Life Questionnaire and the generic Health Related Quality of Life Questionnaire‐SF‐36 in 38 patients with DKD on dialysis aimed at describing the quality of life as compared to 40 non‐diabetic patients on dialysis and 38 patients with long term diabetes but with normal kidney function. The self‐rated physical function and physical health were significantly lower in the DKD group as compared to the non‐diabetic dialysis control and to the diabetic control patients with no kidney disease. The physical role, general health, vitality and emotional role were also scored lower in this group as compared to the diabetic controls. The DKD patients on dialysis exhibited reduced physical health, limitations in the activities of daily living and compromised social roles.31 A review of the literature of 118 studies on health‐related quality of life among patients with type two diabetes highlights the heterogeneity of the results, which is predominantly due to heterogeneity of the diabetic population.32 A recent study confirmed the significantly impaired physical health perception in the DKD patients on dialysis as compared to their non‐diabetic on dialysis control.33 It can therefore be surmised that the DKD population is unique and cannot simply be considered to be a subpopulation of the group of diabetic or kidney disease patients. Therefore, transferability of findings from previous systematic reviews to the DKD patient population, which is challenged by complex multisystem complications, is questionable. None of these chronic disease management strategies have been specifically assessed in terms of their impact on the outcomes of patients with DKD. A recent systematic review of multidisciplinary approaches in the management of patients with chronic kidney disease pre‐dialysis included four articles; two randomized clinical trials and two observational studies. This review highlighted the effectiveness of this type of care management in delaying the progression of the disease based on the results of both randomized controlled trials and observational studies, each with equal input. The included studies focused primarily on educational interventions and none involved a targeted self‐management approach, home visit follow up or technology based (e‐health) follow up.34 In light of this gap in the literature, there is a need to examine the existing evidence regarding multidisciplinary approaches specific to the management of DKD. DKD presents multiple medical management challenges and has a significant impact on the daily lives of patients living with this condition. Considering the global trends and predicted increase in the prevalence of DKD, healthcare systems are faced with major financial ramifications that demand novel management strategies for delaying the progression of the disease, enhancing self‐care activities and improving the patients' health‐related outcomes. The authors propose a systematic review of multidisciplinary management of DKD involving the structured care plans provided and elaborated in collaboration by more than one healthcare discipline, including physicians, nurses, pharmacists, dieticians, or health educators. Such a review is a fundamental initial step that will help to evaluate whether multidisciplinary disease management can contribute to preserving kidney function and delaying disease progression. Such a review will enable: i) identification of the gaps in knowledge and research in this area; ii) identification of targets for implementing an effective multidisciplinary approach to managing DKD; and iii) development of recommendations for the implementation of an appropriate multidisciplinary approach in a clinical practice setting.